UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000020370 |
|---|---|
| Receipt number | R000023525 |
| Scientific Title | Phase 2 trial of the efficacy and safety of Afatinib for EGFR-TKI untreated EGFR gene mutation-Positive Elderly advanced or recurrent non-small cell lung Cancer. (APEC) |
| Date of disclosure of the study information | 2015/12/27 |
| Last modified on | 2018/12/30 11:22:41 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2015/12/27 21:45:32 | ||
| 2 | Update | 2016/12/26 18:10:04 | Organization Organization Division name Division name Address Address TEL Last name of contact person Last name of contact person Division name Organization Organization Division name Division name Address Address TEL Name of primary person or sponsor Organization Email1 Institutions |
|
| 3 | Update | 2017/06/28 10:31:58 | Organization Organization Division name Division name Address Address TEL Organization1 Address1 Tel1 Email1 Institutions |
|
| 4 | Update | 2017/06/28 10:36:18 | Last follow-up date |
|
| 5 | Update | 2018/12/30 11:22:41 | Recruitment status Last follow-up date |
